HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.053967v1 49/10/1715    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Higuchi, T. Articles by Schwaiger, M. Search for Related Content PubMed PubMed Citation Articles by Higuchi, T. Articles by Schwaiger, M.

A New ¹⁸F-Labeled Myocardial PET Tracer: Myocardial Uptake After Permanent and Transient Coronary Occlusion in Rats

¹ Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; and ² Departments of Discovery Chemistry and Discovery Biology, Bristol-Myers Squibb Medical Imaging, North Billerica, Massachusetts

Correspondence: For correspondence or reprints contact: Takahiro Higuchi, Nuklearmedizinische Klinik der Technischen Universität München, Ismaninger Strasse 22, 81675 Munich, Germany. E-mail: higuchi{at}po2.nsknet.or.jp

Conventional myocardial perfusion PET tracers require onsite tracer production because of their short radioactive half-lives. To investigate the potential of a new ¹⁸F-labeled pyridazinone analog (¹⁸F-BMS-747158-02), we characterized this tracer in a rat model of permanent and transient coronary occlusion using small-animal PET. Methods: Myocardial ¹⁸F-BMS-747158-02 distribution in healthy rats (n = 7), rats with transient (3-min) left coronary artery occlusion (n = 11), and rats with permanent left coronary occlusion (n = 11) was analyzed with a dedicated small-animal PET scanner. Results: Normal hearts demonstrated intense and almost homogeneous tracer uptake throughout the left ventricle for more than 2 h. During permanent coronary occlusion, PET demonstrated perfusion defects, which remained unchanged (37.6% ± 8.8%, 37.4% ± 10.2%, and 36.2% ± 9.8% left ventricle at 15, 45, and 115 min, respectively, after tracer injection). After transient ischemia, the induced defect size decreased significantly after reperfusion (16.2% ± 9.3%, 6.0% ± 6.5%, and 1.4% ± 1.3% left ventricle). Tracer reinjection after transient ischemia resulted in normalization of the induced defect. Conclusion: Coronary occlusion yielded distinct myocardial ¹⁸F-BMS-747158-02 uptake defects in the area of ischemia, which demonstrated normalization of activity after reperfusion and reinjection. These promising kinetic parameters may allow for assessment of flow using exercise–rest protocols similar to those used in combination with exercise and rest perfusion SPECT.

Key Words: cardiology (clinical) • PET • animal imaging • ¹⁸F • infarction • ischemia • perfusion

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				S.G. Nekolla, S. Reder, A. Saraste, T. Higuchi, G. Dzewas, A. Preissel, M. Huisman, T. Poethko, T. Schuster, M. Yu, et al. Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model Circulation, May 5, 2009; 119(17): 2333 - 2342. [Abstract] [Full Text] [PDF]

				H. M. Sherif, A. Saraste, E. Weidl, A. W. Weber, T. Higuchi, S. Reder, T. Poethko, G. Henriksen, D. Casebier, S. Robinson, et al. Evaluation of a Novel 18F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats Circ Cardiovasc Imaging, March 1, 2009; 2(2): 77 - 84. [Abstract] [Full Text] [PDF]